Should You Buy Arcutis Biotherapeutics Inc (ARQT) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast ARQT stock price to rise
7 Analyst Rating
Wall Street analysts forecast ARQT stock price to rise
7 Buy
0 Hold
0 Sell
Strong Buy
Current: 21.440
Low
30
Averages
32
High
37
Current: 21.440
Low
30
Averages
32
High
37
Morgan Stanley
Overweight
downgrade
$35 -> $34
AI Analysis
2026-05-07
Reason
Morgan Stanley
Price Target
$35 -> $34
AI Analysis
2026-05-07
downgrade
Overweight
Reason
Morgan Stanley lowered the firm's price target on Arcutis Biotherapeutics to $34 from $35 and keeps an Overweight rating on the shares.
Mizuho
Outperform
downgrade
$37 -> $35
2026-03-02
Reason
Mizuho
Price Target
$37 -> $35
2026-03-02
downgrade
Outperform
Reason
Mizuho lowered the firm's price target on Arcutis Biotherapeutics to $35 from $37 and keeps an Outperform rating on the shares. The firm updated the company's model post the Q4 report.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ARQT
